FDA Decision on Replimune (NASDAQ:REPL) Prompts $763 Million in Melanoma Stock Shifts

FDA Decision on Replimune (NASDAQ:REPL) Prompts $763 Million in Melanoma Stock Shifts

A positive FDA decision triggered the movement of nearly $763 million between two melanoma stocks on Friday. Replimune Group saw an increase of around $486 million, while Iovance Biotherapeutics lost approximately $277 million. These figures are based on the most recent common-share counts reported by the companies.

Latest

Southwest Airlines (NYSE:LUV) Maintains Usual Boarding Process as Revenue Pressure Grows, Elevating Performance Risks

Southwest Airlines (NYSE:LUV) Maintains Usual Boarding Process as Revenue Pressure Grows, Elevating Performance Risks

Southwest has not shifted passenger boarding times to an earlier slot. Beginning August 1, select flight attendants on some routes will report five minutes earlier. Passengers will continue to board 30 to 45 minutes prior to departure, with no modifications to the schedule. Multiple travel outlets had conflated these unrelated adjustments.
Stock Market Today: Live Updates 04.08.2026

Stock Market Today: Live Updates 04.08.2026

LIVEMarkets rolling coverageStarted: August 4, 2026, 4:00 AM EDTUpdated: August 4, 2026, 8:23 AM EDT Unitree Technology Set for Over 7.4 Billion Yuan Valuation in Shanghai IPO, Says Citic Securities August 4, 2026, 8:23 AM EDT. Chinese robotics company Unitree Technology is expected to achieve a valuation exceeding 50 billion yuan ($7.4 billion) after its planned Shanghai IPO, according to Citic Securities, which is sponsoring the offering. Chinese robot maker Unitree seen worth over $7.4 billion yuan after IPO, Citic says Markets Rally at Mid-Summer High While Palantir's Results Impress and AI Security Faces Review August 4, 2026, 8:22 AM
04 Aug